Protease Inhibitors

Application Protein degrader builiding block Pomalidomide-PEG 6 -butyl azide enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology . This conjugate contains a Cereblon

Application Protein degrader builiding block Pomalidomide-PEG 6 -CO 2 H enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology . This conjugate contains a Cereblon

Application Protein degrader builiding block Pomalidomide-PEG 6 -NH 2 (HCl salt) enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology . This conjugate contains a Cereblon

Application Protein degrader building block Pomalidomide-piperazine-piperidine-4-carboxamide hydrochloride enables the synthesis of molecules for targeted protein degradation and PROTAC &#174 (proteolysis-targeting chimeras) research. This

Aeruginosamides are linear ribosomal peptides found in cyanobacteria such as Microcystis aeruginosa. Like other cyanotoxins, aeruginosamides may inhibit serine proteases and protein phosphatases (PPs) or exhibit antithrombotic activity.

Aeruginosamides are linear ribosomal peptides found in cyanobacteria such as Microcystis aeruginosa. Like other cyanotoxins, aeruginosamides may inhibit serine proteases and protein phosphatases (PPs) or exhibit antithrombotic activity.

Aeruginosamides are linear ribosomal peptides found in cyanobacteria such as Microcystis aeruginosa. Like other cyanotoxins, aeruginosamides may inhibit serine proteases and protein phosphatases (PPs) or exhibit antithrombotic activity.

Aeruginosamides are linear ribosomal peptides found in cyanobacteria such as Microcystis aeruginosa. Like other cyanotoxins, aeruginosamides may inhibit serine proteases and protein phosphatases (PPs) or exhibit antithrombotic activity.

Pradefovir mesylate is a good substrate for liver CYP3A4. Pradefovir is converted to 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in human liver microsomes with a K m of 60 μM.In VitroPradefovir is a cyclodiester prodrug of PMEA. It is one of the

Pradefovir mesylate is a good substrate for liver CYP3A4. Pradefovir is converted to 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in human liver microsomes with a K m of 60 μM.In VitroPradefovir is a cyclodiester prodrug of PMEA. It is one of the

Pradefovir mesylate is a good substrate for liver CYP3A4. Pradefovir is converted to 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in human liver microsomes with a K m of 60 μM.In VitroPradefovir is a cyclodiester prodrug of PMEA. It is one of the

Pradefovir mesylate is a good substrate for liver CYP3A4. Pradefovir is converted to 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in human liver microsomes with a K m of 60 μM.In VitroPradefovir is a cyclodiester prodrug of PMEA. It is one of the